The Division of Endocrinology and the Pharmacy and Therapeutics Committee has approved a therapeutic interchange for insulin detemir (Levemir®). |
Read more >>
Arron J. Vickery
Senior Director - Information Technology
avickery@umc.edu
Helpful Links: DIS Newsletter Archive,
|